SEC Comment Letter 0000000000-23-008634 to ENvue Medical, Inc. (FEED)
ENvue Medical, Inc.
Date: Aug. 9, 2023 · CIK: 0001326706 · Accession: 0000000000-23-008634
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-273574
Letter
United States securities and exchange commission logo August 8, 2023 Stephen Brown Chief Financial Officer NanoVibronix, Inc. 525 Executive Boulevard Elmsford, NY 10523 Re:NanoVibronix, Inc. Registration Statement on Form S-3 Filed August 1, 2023 File No. 333-273574 Dear Stephen Brown: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Abby Adams at (202) 551-6902 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Jayun Koo, Esq.
Show Raw Text
United States securities and exchange commission logo
August 8, 2023
Stephen Brown
Chief Financial Officer
NanoVibronix, Inc.
525 Executive Boulevard
Elmsford, NY 10523
Re:NanoVibronix, Inc.
Registration Statement on Form S-3
Filed August 1, 2023
File No. 333-273574
Dear Stephen Brown:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Abby Adams at (202) 551-6902 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Jayun Koo, Esq.